Fusion AI

Fusion AI, based in China, develops innovative AI solutions aimed at enhancing hospital operations and healthcare processes through advanced technology. Fusion AI was founded in 2015 in Hangzhou, China, focusing on creating AI-driven solutions for healthcare environments. The company has received CNY 50. 00 mn in funding as of November 2025, led by Marathon Venture Partners and supported by Long Hill Capital.

This funding is aimed at technology iteration and nationwide deployment of their products. Fusion AI specializes in AI-driven solutions for hospitals, optimizing healthcare processes. Their offerings include generative AI applications that enhance clinical workflows, patient care, and administrative efficiency, aiming to streamline patient management and improve diagnostic accuracy. Their technology is utilized by various healthcare institutions across North America and Europe, benefiting a wide range of stakeholders from medical practitioners to administrative staff.

Fusion AI operates on a B2B partnership model, primarily through subscription agreements with healthcare institutions. Clients engage in contracts that provide software licenses and continuous support for the generative AI applications, ensuring integration into existing systems while receiving ongoing updates. This subscription structure generates a stable revenue stream, facilitating the ongoing development of the product suite. In November 2025, Fusion AI successfully raised CNY 50 million in pre-Series A funding, which will primarily support the technological iteration of their medical AI products and facilitate large-scale deployment across the nation.

The company aims to expand its market presence and enhance its talent team to maintain a strong position in the medical AI sector.